We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Correcting sickle cell–causing mutation with efficient CRISPR-Cas9 genome editing

Product News   Aug 10, 2018

 
Correcting sickle cell–causing mutation with efficient CRISPR-Cas9 genome editing
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Bio-Rad Launches the SEQuoia RiboDepletion Kit for Next-Generation Sequencing

Product News

Bio-Rad Laboratories, Inc. has announced the launch of the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library.

READ MORE

ERS Genomics and GenScript Biotech Corporation Sign CRISPR/Cas9 License Agreement

Product News

ERS Genomics Limited and GenScript Biotech Corporation have announced a non-exclusive license agreement granting GenScript access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

READ MORE

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research

Product News

Flow Eighteen38 and FairJourney Biologics S.A. have announced an agreement with the Hubrecht Institute to harness the potential of FJB’s proprietary llama naïve libraries to develop antibodies to be used as research tools.

READ MORE

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE